Share
Market Research Report

HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Transplant TypeAllogeneic · Autologous
  • By IndicationAcute Myeloid Leukemia (AML) · Acute Lymphoblastic Leukemia (ALL) · Hodgkin lymphoma (HL) · Non-Hodgkin Lymphoma (NHL) · Multiple Myeloma (MM) · Others
  • By ApplicationBone Marrow Transplant (BMT) · Peripheral Blood Stem Cells Transplant (PBSCT) · Cord Blood Transplant (CBT)
  • By End UserHospitals · Specialty Clinics · Others
  • By RegionNorth America · Latin America · Europe · Asia Pacific · Middle East · and Africa
  • Published In28 Apr 2026
  • Report CodeCMI1250
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Transplant Type
      • Market Snippet, By Indication
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Recent Test Launches
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
  4. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Transplant Type,

    2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Allogeneic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Autologous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  5. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Indication, 2021 – 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Acute Myeloid Leukemia (AML)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Acute Lymphoblastic Leukemia (ALL)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Hodgkin lymphoma (HL)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Non-Hodgkin Lymphoma (NHL)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Multiple Myeloma (MM)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  6. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Application, 2021 – 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Bone Marrow Transplant (BMT)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Peripheral Blood Stem Cells Transplant (PBSCT)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Cord Blood Transplant (CBT)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  7. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By End User, 2021 – 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Specialty Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  8. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Region, 2021 – 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Transplant Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 –2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Application, 2021–2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Transplant Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 –2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Application, 2021–2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Transplant Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 –2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Application, 2021–2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Transplant Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 –2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Application, 2021–2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Transplant Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 –2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Application, 2021–2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Transplant Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 –2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Application, 2021–2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region,  2021 –2033, (US$ Bn)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape

    • Company Profiles
      • Pluristem Therapeutics Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • CellGenix GmbH
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Regen Biopharma Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Lonza Group
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Kiadis Pharma
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Taiga Biotechnologies, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Takeda Pharmaceutical Company Limited
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Escape Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Bluebird Bio,Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Talaris Therapeutics, Inc.,
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Marker Therapeutics Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Stempeutics Research Pvt Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • CBR Systems Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Priothera Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Eurobio Scientific Group
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Otsuka America Pharmaceutical, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Pfizer Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Sanofi
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • FUJIFILM Holdings Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
  10. Section

    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 38 market data tables and 33 figures on “Global Hematopoietic Stem Cell Transplantation (HSCT) Market” – Global forecast to 2033